Vol 62, No Supplement 22 | The Journal of Clinical Psychiatry

Article

Introduction: The Role of Enteric-Coated Fluoxetine Once-Weekly in Achieving Optimal Outcomes in the Long-Term Treatment of Depression

J Clin Psychiatry 2001;62(suppl 22):3-4

David J. Kupfer, MD

Article

The Burden of Recurrent Depression: Causes, Consequences, and Future Prospects

J Clin Psychiatry 2001;62(suppl 22):5-9

John F. Greden, MD

Article

Treatment Recommendations Versus Treatment Realities: Recognizing the Rift and Understanding the Consequences

J Clin Psychiatry 2001;62(suppl 22):10-15

Ellen Frank, PhD ; Rajinder Judge, MD

Article

Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression

J Clin Psychiatry 2001;62(suppl 22):16-23

Frederick W. Reimherr, MD ; Robert E. Strong, DO ; Barrie K. Marchant, MS ; Dawson W. Hedges, MD ; Paul H. Wender, MD

Article

Fluoxetine: A Suitable Long-Term Treatment.

J Clin Psychiatry 2001;62(suppl 22):24-29

Helena Maria Calil, MD, PhD

Article

Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events.

J Clin Psychiatry 2001;62(suppl 22):30-33

Koen Demyttenaere, MD, PhD ; Paul Enzlin, MS ; Walthère Dewè, PhD ; Bruno Boulanger, PhD ; Jozef De Bie, MD ; Wim De Troyer, MD ; Patrick Mesters, MD

Article

Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment

J Clin Psychiatry 2001;62(suppl 22):34-37

Koen Demyttenaere, MD, PhD ; Paul Enzlin, MS ; Walthère Dewè, PhD ; Bruno Boulanger, PhD ; Jozef De Bie, MD ; Wim De Troyer, MD ; Patrick Mesters, MD

Article

Exploring Treatment Alternatives: Weekly Dosing of Fluoxetine for the Continuation Phase of Major Depressive Disorder

J Clin Psychiatry 2001;62(suppl 22):38-42

William J. Burke, MD ; Delores A. McArthur-Miller, MA

Article

Patient Compliance With Enteric-Coated Weekly Fluoxetine During Continuation Treatment of Major Depressive Disorder

J Clin Psychiatry 2001;62(suppl 22):43-47

Erik de Klerk, MD, MSc

Article

Efficacy and Safety of Weekly Treatment With Enteric-Coated Fluoxetine in Patients With Major Depressive Disorder

J Clin Psychiatry 2001;62(suppl 22):48-52

Timothy G. Dinan, MD, PhD

Article

Patient Perspectives on Once-Weekly Fluoxetine.

J Clin Psychiatry 2001;62(suppl 22):53-57

Rajinder Judge, MD

Volume 62 • 2001 • Supplement 22

Article

Introduction: The Role of Enteric-Coated Fluoxetine Once-Weekly in Achieving Optimal Outcomes in the Long-Term Treatment of Depression

The Burden of Recurrent Depression: Causes, Consequences, and Future Prospects

Treatment Recommendations Versus Treatment Realities: Recognizing the Rift and Understanding the Consequences

Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression

Fluoxetine: A Suitable Long-Term Treatment.

Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events.

Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment

Exploring Treatment Alternatives: Weekly Dosing of Fluoxetine for the Continuation Phase of Major Depressive Disorder

Patient Compliance With Enteric-Coated Weekly Fluoxetine During Continuation Treatment of Major Depressive Disorder

Efficacy and Safety of Weekly Treatment With Enteric-Coated Fluoxetine in Patients With Major Depressive Disorder

Patient Perspectives on Once-Weekly Fluoxetine.

ELSEWHERE:

FOLLOW US:

Volume 62 • 2001 • Supplement 22

Article

Introduction: The Role of Enteric-Coated Fluoxetine Once-Weekly in Achieving Optimal Outcomes in the Long-Term Treatment of Depression

The Burden of Recurrent Depression: Causes, Consequences, and Future Prospects

Treatment Recommendations Versus Treatment Realities: Recognizing the Rift and Understanding the Consequences

Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression

Fluoxetine: A Suitable Long-Term Treatment.

Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events.

Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment

Exploring Treatment Alternatives: Weekly Dosing of Fluoxetine for the Continuation Phase of Major Depressive Disorder

Patient Compliance With Enteric-Coated Weekly Fluoxetine During Continuation Treatment of Major Depressive Disorder

Efficacy and Safety of Weekly Treatment With Enteric-Coated Fluoxetine in Patients With Major Depressive Disorder

Patient Perspectives on Once-Weekly Fluoxetine.

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles